These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2115831)

  • 1. Neutrophil functional and arachidonic acid metabolic correlates and clinical disease activity in pirazolac-treated rheumatoid arthritis patients.
    Turner RA; Johnson JA; Turner SR; McGee M; Kashanian F
    Drugs Exp Clin Res; 1990; 16(1):39-48. PubMed ID: 2115831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil responsiveness to chemoattractant tripeptide in rheumatoid arthritis.
    Turner RA; Johnson JA; Turner SR
    Proc Soc Exp Biol Med; 1987 Nov; 186(2):125-33. PubMed ID: 3671351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
    Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory lipoxygenase products from peripheral mononuclear cells in patients with rheumatoid arthritis.
    Colli S; Caruso D; Stragliotto E; Morazzoni G; Aletti A; Galli G; Canesi BA; Tremoli E
    J Lab Clin Med; 1988 Sep; 112(3):357-62. PubMed ID: 2842416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in arachidonic acid metabolism and chemotactic response in polymorphonuclear leukocytes from patients with rheumatoid arthritis.
    Smith DM; Johnson JA; Turner RA
    Clin Exp Rheumatol; 1989; 7(5):471-7. PubMed ID: 2556230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids.
    Goetzl EJ; Brash AR; Tauber AI; Oates JA; Hubbard WC
    Immunology; 1980 Apr; 39(4):491-501. PubMed ID: 6247265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of novel lipoxygenase products on neutrophil and eosinophil functions in vitro.
    Palmblad J; Udén AM; Friberg I; Ringertz B; Rådmark O; Lindgren JA; Hansson G; Malmsten CL
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():25-31. PubMed ID: 6303087
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion.
    Nigam S; Fiore S; Luscinskas FW; Serhan CN
    J Cell Physiol; 1990 Jun; 143(3):512-23. PubMed ID: 2162850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.
    Schleimer RP; Freeland HS; Peters SP; Brown KE; Derse CP
    J Pharmacol Exp Ther; 1989 Aug; 250(2):598-605. PubMed ID: 2547940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay.
    Quitt M; Torres M; McGuire W; Beyer L; Coates TD
    J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre double-blind study of the efficacy, safety and tolerance of pirazolac compared with sulindac in patients with rheumatoid arthritis.
    Numo R
    Drugs Exp Clin Res; 1990; 16(1):17-27. PubMed ID: 2198156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of the amide bond at position 3 in fMLP analogs select neutrophil functions.
    Spisani S; Breveglieri A; Fabbri E; Vertuani G; Rizzuti O; Cavicchioni G
    Pept Res; 1996; 9(6):279-82. PubMed ID: 9048420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxy radical as autotoxin in chemotactically activated neutrophils.
    Till GO; Lutz MJ; Ward PA
    Biomed Pharmacother; 1987; 41(6):349-54. PubMed ID: 2833323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy.
    Mendonça MA; Cunha FQ; Murta EF; Tavares-Murta BM
    Cancer Chemother Pharmacol; 2006 May; 57(5):663-70. PubMed ID: 16133528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).
    Goetzl EJ; Pickett WC
    J Immunol; 1980 Oct; 125(4):1789-91. PubMed ID: 7410854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis.
    Hattar K; Sibelius U; Bickenbach A; Csernok E; Seeger W; Grimminger F
    J Leukoc Biol; 2001 Jan; 69(1):89-97. PubMed ID: 11200073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil chemotaxis in rhesus macaques (Macaca mulatta).
    Gonder JC; Thomas JM; Payne ES
    Am J Vet Res; 1986 Apr; 47(4):860-2. PubMed ID: 3963588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of chemotactic factor-induced neutrophil responsiveness by arachidonic acid.
    Naccache PH; Molski TF; Volpi M; Mackin WM; Becker EL; Sha'afi RI
    J Cell Physiol; 1983 Jun; 115(3):243-8. PubMed ID: 6406520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.